Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer
M Bauer,1 J Bryce,2 P Hadji11University of Marburg, Marburg, Germany; 2National Cancer Institute, Naples, ItalyAbstract: Postmenopausal women have an increased risk of osteopenia and osteoporosis due to loss of the bone-protective effects of estrogen. Disease-related processes may also contribute to...
| मुख्य लेखकों: | , , |
|---|---|
| स्वरूप: | लेख |
| भाषा: | English |
| प्रकाशित: |
Dove Medical Press
2012-06-01
|
| श्रृंखला: | Breast Cancer: Targets and Therapy |
| ऑनलाइन पहुंच: | http://www.dovepress.com/aromatase-inhibitor-associated-bone-loss-and-its-management-with-bisph-a10182 |